JPMorgan lowered the firm’s price target on Nutanix (NTNX) to $65 from $78 and keeps an Overweight rating on the shares following the fiscal Q1 report. The firm says increased mix of delayed deployment bookings brought a reduced revenue outlook. However, Nutanix’s bookings remain “robust,” the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $82 from $90 at Morgan Stanley
- Nutanix price target lowered to $72 from $88 at Piper Sandler
- Nutanix: Strong Fundamentals and Financial Resilience Justify Buy Rating Despite Revenue Timing Challenges
- Nutanix price target lowered to $65 from $95 at KeyBanc
- Nutanix price target lowered to $57 from $71 at Wells Fargo